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INTRODUCTION

IN THE PAST FEW YEARS, THERE HAS BEEN KEEN IN-TEREST IN THE ELECTROPHYSIOLOGY AND FUNCTION-AL SIGNIFICANCE OF RAPID EYE MOVEMENT (REM)
sleep. It supports the highest frequency and intensity of dreaming and plays a key role in learning and memory processes, and its electroencephalogram (EEG) bears a marked similarity to that of waking. [1] [2] [3] Slow-wave sleep (SWS) has also been increasingly investigated in terms of its EEG rich in slow-wave activity (SWA), its involvement in recovery processes, and its role in information transfer of waking performance. [4] [5] [6] In contrast, little attention has been paid to sleep stage 2, although it occupies about 50% of the sleep time. In the Rechtschaffen and Kales 8 sleep-stage scoring procedure, stage 2 is defined by "the presence of sleep spindles and K complexes, and the absence of sufficient high-amplitude, slow activity to define the presence of stages 3 and 4." However, some sleep researchers do not hold this conventional view. They advance that the EEG of sleep stage 2 is not uniform throughout the night. They distinguish a sleep stage 2 that ensures the transition to SWS with a progressive enrichment in SWA and a prevalence of K-complexes 7 from another sleep stage 2 that evolves toward REM sleep, characterized by an abrupt decrease in SWA, and a diminution of K complexes and sleep spindles.
We provide here further evidence of the nonuniformity of sleep stage 2 on the basis of its autonomic and hormonal background. Autonomic activity is inferred from heart rate variability (HRV) analysis, with special attention to global variability (SDNN, standard deviation of normalized R-R intervals) and to HRV indexes reflecting sympathovagal balance, i.e., the normalized low-frequency power (LF/ [LF+HF] , where LF is low-frequency power and HF is the high-frequency power) [9] [10] [11] and the interbeat autocorrelation coefficient of R-R intervals (rRR). 12 Several studies have indicated that REM sleep is characterized by higher SDNN, LF/(LF+HF), and rRR than SWS, [13] [14] [15] [16] with switches during the night from parasympathetic-dominated SWS to sympatheticdominated REM sleep. 12, 17 A number of hormones have been reported to fluctuate in temporal association with EEG activity during sleep. [18] [19] [20] Especially renin, a key enzyme of the renin-angiotensin system involved in blood pressure control, is considered to be a biologic marker of sleep-stage alternation. [21] [22] [23] Cortisol, a marker of the activating adrenocorticotropic system, presents a more complicated picture because of its circadian rhythm, displaying a quiescent period of secretion at the beginning of the night when SWA oscillates with greatest amplitude. At the end of the night, when cortisol secretory pulses and oscillations in SWA are simultaneously present, the 2 rhythms are found to be synchronized in phase opposition, with cortisol changes preceding SWA variations by about 10 minutes. 20, 24 In the present study, we examined the autonomic and hormone profiles with particular regard to sleep stage 2, when it evolves toward SWS and toward REM sleep. The hypnograms have been normalized by a method derived from Achermann et al 25 so that the duration of well-defined sleep stages can be averaged among subjects and characterized for their neuroendocrine properties.
METHODS
Subjects and Procedure
Fourteen healthy male subjects, aged 21 to 29 years and having a body mass index of 22.5 ± 0.4 kg/m², participated in the study after medical examination. All the subjects had normal regular sleep-wake habits, and none took any medication the 2 weeks before or during the study. Subjects with signs of disease and smokers were excluded. Informed written consent was obtained from all subjects, and the experiment was approved by the local ethics committee.
The experiments were carried out in a soundproof, air-conditioned sleep room. After a habituation night, which allows screening for sleep pathologies, all subjects underwent 1 experimental night during which sleep and cardiac recordings and blood samplings were simultaneously carried out. Electrodes for sleep and electrocardiographic (ECG) recordings were applied 2 hours before the beginning of the experiment. The subjects were supine at 9:00 PM, lights were switched off at 11:00 PM, and the subjects were awakened at 7:00 AM.
Sleep Analysis
Sleep recordings were taken from 11:00 PM to 7:00 AM with a sampling frequency of 256 Hz using an Astro-med EEG system (Grass Instruments, West Warwick, RI). Four EEG (F3, C3, P3 vs A2 and C4 vs A1), 1 chin electromyogram, and 1 electrooculogram were recorded. They were visually scored at 30-second intervals using standardized criteria. 8 For all-night spectral analysis, which provides a dynamic description of sleep, the EEG signal (C3-A2 or C4-A1) was high-pass (0.5Hz) and low-pass (35 Hz) filtered before being analog-to-digital converted. Occasional alterations in the signal due to body movements, electrode detachment, and any kind of noises were visually detected, and periods containing these artifacts were discarded from further analysis. Absolute power spectra were computed for consecutive 2-second periods using a fast Fourier transform algorithm. Data were then averaged to yield a median estimation for every 10 minutes. The spectral parameter studied was the absolute power in the delta frequency band (0.5-3.5 Hz).
Heart Rate Analysis
The ECG was recorded from 11:00 PM to 7:00 AM using the Astro-Med system with a sampling frequency of 256 Hz that ensures the recognition of physiologic variations in R-R intervals above 4 milliseconds. The continuous ECG signal was obtained with a modified C5 lead connecting the electrodes to an analog amplifier. The R-R sequence was then extracted from the ECG signal using an automated R-R extraction algorithm (R-R interval software, Astro-Med EEG system). The R-R intervals were calculated and checked for artifacts. Occasional ectopic beats were identified and replaced with interpolative R-R interval data. SDNN and rRR were calculated for each 10-minute period. Power spectral analysis of each consecutive 10-minute recording was performed sequentially with a fast Fourier transform based on a nonparametric algorithm using a Welsh window after the ectopic-free data were detrended and resampled. A fixed resampling frequency of 1024 equally spaced points in 10-minute periods was used. The power densities in the LF band (0.04-0.15 Hz) and in the HF band (0.15-0.50 Hz) were calculated for each 10-minute period by integrating the spectral power density in the respective frequency bands. The normalized LF power ratio (LF/[LF+HF]) was then calculated.
Blood Sampling and Plasma Hormone Measurements
Four hours before the beginning of the recordings, a catheter kept patent with a heparin-containing solution was inserted into an antecubital vein under local anesthesia. Blood was sampled continuously from 11:00 PM to 7:00 AM by use of a peristaltic pump and was collected in EDTA-K2 tubes in an adjoining room every 10 minutes. Samples were immediately centrifuged at 4°C, and the plasma was stored at -25°C until assay. A maximum of 150 mL of blood was removed during the 8-hour period.
Plasma cortisol was measured by radioimmunoassay using commercial assay kits (Ciba Corning, Inc. Diagnostics, CergyPontoise, France). The detection limit was 2 ng/mL. The intraassay coefficient of variation (CV) for duplicate samples was 10% for levels less than 60 ng/mL and 4% for levels above 60 ng/mL. Plasma renin activity (PRA) was measured by radioimmunoassay of angiotensin I generated after incubation of the plasma (Commercial Kits, Sorin Biomedica, Saluggia, Italy). The intraassay CV for duplicate samples was 4% for levels between 10 and 20 ng/mL per hour, 6% for levels between 2 and 10 ng/mL per hour, 10% for levels between 1 and 2 ng/mL per hour, and 30% for levels below 1 ng/mL per hour. The detection limit was 0.18 ng/mL per hour. All samples from 1 subject were measured in the same run to avoid interassay variations.
Statistical Analysis
To establish the mean profiles of the 14 subjects, the individual durations of the sleep episodes were normalized according to a previously described method. 25 Individual data in sleep stage 2, SWS, and REM sleep episodes during the first 3 non-REM (NREM)-REM sleep cycles were subdivided into equal parts. These sleep cycles were free of intrasleep awakenings lasting more than 2 minutes. The mean duration of successive sleep stages was then calculated and plotted against the EEG, autonomic, and hormone profiles. Mean changes of each variable in each NREM-REM sleep cycle were analyzed by 1-way analysis of variance for repeated measures with time as a factor. The Neuman-Keuls test was used for posthoc multiple comparisons between mean values of SWA, HRV indexes, and hormones. Paired t tests were used to assess the statistical significance of differences between 5-minute segments of sleep stage 2 free of arousals and body movements and separated from subsequent SWS, REM sleep, or wake by 5 minutes. Data were averaged over each subject and then over all the subjects. A difference was considered significant when P < .05. Results are given as mean ± SEM.
The temporal link between the overnight profiles in SWA and HRV indexes was quantified using cross-correlation analysis for lags -2 to +2, each lag corresponding to a 10-minute interval. The highest cross-correlation coefficient was then identified with its level of significance. The quantification of the relationships between overnight variations of SWA and cortisol levels was limited to the period that began with the onset of the first secretory episode determined for each subject, the duration of this period being subject dependent. This secretory episode was identified using a pulse-detection program that takes into account the limit of detection of the analytical procedure and the precision of the assay for various concentration ranges. For PRA, a least-squared polynome was adjusted to the nocturnal profiles, and the polynomial values were substracted point by point from the series of PRA levels. The residual data were then used for cross-correlation analysis. Figure 1 illustrates the mean normalized hypnograms, mean profiles in SWA, and the concomitant profiles of SDNN, LF/ (LF+HF), and rRR, during 3 normalized NREM-REM sleep cycles of the 14 subjects. Table 1 gives the mean peak and trough values of SWA and the different HRV indexes during SWS and REM sleep. Table 2 Figure 2 presents the mean normalized hypnograms and the concomitant profiles in SWA, plasma cortisol level, and PRA. in all subjects, gives better insight into the relationship between the hormone profile and sleep stage 2. Cortisol was stable during sleep stage 2 preparing SWS, remained stable until the end of SWS, and then significantly (P < .01) increased during sleep stage 2 preceding REM sleep. Cortisol levels remained high until the end of REM sleep episodes. Cortisol in its active period of secretion was negatively correlated with SWA in all subjects. The cross-correlation coefficients ranged between -0.374 and 0.712 (P < .01), with cortisol preceding SWA by 10-20 minutes.
RESULTS
In each sleep cycle, the increase in PRA levels was initiated in sleep stage 2 preparing SWS during which PRA was higher (Table 3 and 4) . It had a tendency to decrease during sleep stage 2 preparing REM sleep and was lower during REM sleep. SWA variations preceded PRA by 10 minutes (cross-correlation coefficients: 0.434-0.758; P < .01).
DISCUSSION
In its earliest and still-recognized terminology, sleep stage 2 has been defined as a homogeneous stage of sleep characterized by the absence of SWA of sufficiently high amplitude to define the presence of stages 3 and 4.
8 Certain researchers, however, consider that the EEG of sleep stage 2 is not uniform. It is recognized that sleep stage 2 ensuring the transition toward REM sleep is poor in spindles and K complexes. It is characterized by an abrupt decrease in SWA and lower voltage than the sleep stage 2 that occurs before SWS, when a progressive enrichment in SWA is seen. We confirm here the duality of sleep stage 2 on the basis of its autonomic and hormonal background.
Striking differences appear in the activity of the autonomic nervous system that clearly identify 2 types of sleep stage 2. Autonomic activity was inferred both from the normalized LF/(LF+HF) ratio, which can be considered, although not unanimously, 26, 27 as an index of sympathovagal balance, [9] [10] [11] and from the rRR, which we proposed as a reliable marker of sympathovagal activity during sleep. 12 It is well established that REM sleep is characterized by higher LF/(LF+HF) and rRR than SWS, reflecting higher sympathetic tone during REM sleep, and by higher SDNN, reflecting higher global variability. [13] [14] [15] [16] There are switches throughout the night from a low level of sympathetic activity during SWS to a high level during REM sleep. 12, 16, 17 However on the basis of their autonomic activity, 2 types of sleep stage 2 can be distinguished, i.e., "quiet" sleep stage 2 that prepares SWS with progressively lower LF/(LF+HF) and rRR and "active" sleep stage 2 evolving toward REM sleep with high levels of these HRV indexes. These differences possibly confer a fundamental preparatory role in ultradian sleep regulation on this sleep stage. We have previously reported that cardiac changes precede EEG changes by about 5 minutes when 5-minute periods are taken for HRV analysis. 17 It is then tempting to propose that autonomic activity adjusts in anticipation of sleep-stage alternation and that this oscillatory process may underlie the sleep stage-related changes in cardiovascular and thermoregulatory responses that have been reported in other studies. 28, 29 Importantly, a conservative analysis of 5-minute segments of sleep stage 2 free of any arousal and body movement revealed no significant differences in HRV indexes, indicating that these events that induce abrupt heart rate increases may be responsible for the HRV changes described. These results illus-
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Duality of Sleep Stage 2-Brandenberger et al trate the thorny problem of stationarity of the ECG data required for HRV analysis, which, in strict terms, is unknown to biology. The "percentile" method 25 that we used to average sleep stages of various length within the NREM-REM sleep cycle was particularly appropriate for defining the relationships between hormone profiles and well-defined sleep stage 2, REM sleep, and SWS. The results clearly establish the dual behavior of the activating adrenocorticotropic system in sleep stage 2, which is quiet, with stable cortisol levels when preceding SWS and active during the period preceding REM sleep, with increasing cortisol levels, at least during the pulsatile period of cortisol secretion at the end of the night. These results corroborate previous studies in which we found that slow waves begin to develop when adrenocorticotropic activity is low and, conversely, that the disappearance of slow waves is linked to an increase in cortisol secretion, which suggests that a low activity of the adrenocorticotropic system is a prerequisite for an enrichment in SWA. 20, 24 This dual adrenocorticotropic activity suggests a functional difference for sleep stage 2 and lends support to the concept of a heterogeneous nature of this sleep stage.
Another picture emerges from PRA that reflects renin release. In previous studies, we have described an ultradian rhythm in PRA that parallels overnight oscillations in SWA, with SWA variations preceding PRA oscillations by about 10 minutes. 23 There was a strong concordance between renin and SWA in all situations and pathologies we studied, [31] [32] [33] which led us to hypothesize that common central mechanisms, possibly involving the serotoninergic system, 34, 35 control both the increase in SWA and renin release from the juxtaglomerular cells of the kidney. However, a recent study 36 involving the simultaneous analysis of blood pressure and renin release indicated that nocturnal oscillations in renin may be linked to blood pressure regulation rather than to a direct sleeprelated process controlling both renin release and SWA. Concerning renin, it appears that sleep stage 2 plays a transitional role, initiating higher PRA that peaks during SWS in response to decrease in mean blood pressure. Subsequently PRA decreases to reach a nadir during REM sleep. One could then imagine a simple step function for sleep stage 2, step up from REM sleep to SWS and step down from SWS to REM sleep.
Thus, the continuous evaluation of HRV indexes, together with adrenocorticotropic activity, suggests that activating neuroendocrine processes adjust in relation to sleep events, whereas the renin-angiotensin system intervenes in the sleep stage-dependent blood pressure regulation. Sleep stage 2 represents a pivot, with a quiet period preparing SWS and an active period preceding REM sleep. Sleep stage 2 seems to play a fundamental preparatory role in the oscillatory process of sleep deepening and lightening, which confers a heretofore unrecognized importance in ultradian sleep regulation on this sleep stage. 
